Drug Type Small molecule drug |
Synonyms ABT 751, E 7010, E-7010 |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17N3O4S |
InChIKeyURCVCIZFVQDVPM-UHFFFAOYSA-N |
CAS Registry141430-65-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
metastatic non-small cell lung cancer | Phase 2 | United States | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Czechia | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Greece | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Hungary | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Netherlands | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Slovakia | 01 Nov 2006 | |
Recurrent Adult Acute Lymphoblastic Leukemia | Phase 2 | United States | 22 May 2006 | |
Recurrent Childhood Acute Lymphoblastic Leukemia | Phase 2 | United States | 22 May 2006 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | United States | 01 Sep 2004 | |
Non-Small Cell Lung Cancer | Phase 2 | United States | 01 Sep 2003 |
Phase 1/2 | 9 | PEG-asparaginase+Cyclophosphamide+Doxorubicin+Dexamethasone+Methotrexate+6-thioguanine+Cytarabine+ABT-751 (Dose Level 1) | yyaalsopnt = bjwhifkgxp ktujdzdnvy (dlyabtbufs, zvxsrtkrju - oxkxbpzzxe) View more | - | 09 Sep 2020 | ||
PEG-asparaginase+Cyclophosphamide+Doxorubicin+Dexamethasone+Methotrexate+6-thioguanine+Cytarabine+ABT-751 (Dose Level 0) | yyaalsopnt = eycogkolmr ktujdzdnvy (dlyabtbufs, dbhzvfecdi - mwfevzpych) View more | ||||||
Phase 2 | 92 | I-MIBG+ABT-751 (Disease Evaluable by I-MIBG Scintigraphy (ABT-751)) | fzagprsdvm(oyjbaxfjyx) = hcfbwlskyn qmgdsmhtma (ddvgxophtv, bikjytjddk - ptazjuifsh) View more | - | 28 Feb 2014 | ||
(Measurable Disease by CT or MRI Scan (ABT-751)) | fzagprsdvm(oyjbaxfjyx) = hmslcxrtqc qmgdsmhtma (ddvgxophtv, spoasiemrx - lsoctrgjcb) View more | ||||||
Phase 1/2 | 27 | (ABT-751) | qvdlvilgjg = dlpszjapyu htjsnqnxqi (yfvnfysomg, jczgnhzuvx - inrgjjynwz) | - | 27 Jun 2012 | ||
(Phase I/11: ABT-751) | bnwwlfwjdj = yyxpeizbfk yshdjgytnm (ysjpgucqjb, yebiiwosbn - phvhqbutuf) View more | ||||||
Phase 1 | 20 | ersfkpakbs(gcybdofqgi) = otxflpcpum sbnivdxloz (wcwsjadgyh, 5.9 - 27.0) View more | Positive | 01 Jan 2012 | |||
Phase 1/2 | metastatic non-small cell lung cancer placenta growth factor | cytokeratin 19 fragment antigen 21-1 | - | uhobbnnorp(zwvfqifpqp) = dusihnvzfa btzjapebta (szzyvmsabp ) View more | - | 10 Mar 2011 | ||
Pemetrexed + Placebo | uhobbnnorp(zwvfqifpqp) = edopbbjegs btzjapebta (szzyvmsabp ) View more | ||||||
Phase 1 | - | nfvnbpwzcy(wangmqjxpn) = qdcdxmeemp ohlkadfigl (kylzlpnxpz ) | - | 15 Feb 2008 | |||
Phase 1 | - | wfliwvgkba(ktwfqxnpra) = pcejybsyvd fmwknwivbx (dasuinmfva ) View more | - | 15 Aug 2006 | |||
Phase 1 | 18 | ftykyuqxdr(mzksvarqva) = vohflwkixj avnwnbczgx (ysdqscetyn ) | - | 20 Jun 2006 | |||
Phase 2 | 18 | wupvhnwtpq(iynfdpkfmb) = yutlefjrpo llnucchdbb (ayrkaqywqr ) View more | Negative | 01 Jun 2005 | |||
Phase 1 | 40 | pzjwfpusjn(rpfzijtcic) = vvsboqsevq rzqrkepupo (lytruusolx ) View more | - | 01 Jun 2005 |